|
| AHRQ Releases New Spanish Language Guides For Patients | Wed, 08 Sep 2010 |
| HHS' Agency for Healthcare Research and Quality today released a series of free evidence-based guides designed to help Spanish speakers understand and compare the risks, benefits and side effects of treatments for eight health conditions. The guides provide valuable information that patients can use in talking with their clinicians... | |
|
| Epitwin: Largest Ever Epigenetics Project Launched | Tue, 07 Sep 2010 |
| One of the most ambitious large-scale projects in Human Genetics has been launched: Epitwin will capture the subtle epigenetic signatures that mark the differences between 5,000 twins on a scale and depth never before attempted, providing key therapeutic targets for the development of drug treatments... | |
| Concern About Rosiglitazone (Avandia) And How Drugs Are Regulated And Promoted, BMJ | Mon, 06 Sep 2010 |
| There is serious concern about top-selling diabetes drug rosiglitazone (Avandia), its safety, as well as the whole system by which medications are regulated, evaluated and promoted worldwide, according to a BMJ (British Medical Journal) investigation. Dr. Fiona Godlee, BMJ Editor-in-Chief, thinks Avandia should not have been licensed; she believes it should be withdrawn... | |
|
| Pediatric Weight Expert Provides Obesity Trinity Answers | Mon, 06 Sep 2010 |
| In a first person paper published in the August 27, 2010 issue of Childhood Obesity, Dr. Melinda Sothern, Director of Health Promotion and Professor of Public Health at LSU Health Sciences Center New Orleans, provides three ways to de-program the 1950s obesity trinity underlying the current obesity epidemic in the United States and protect future generations from its health consequences... | |
| Why Fish Oils Work Swimmingly Against Diabetes | Fri, 03 Sep 2010 |
| Researchers at the University of California, San Diego School of Medicine have identified the molecular mechanism that makes omega-3 fatty acids so effective in reducing chronic inflammation and insulin resistance. The discovery could lead to development of a simple dietary remedy for many of the more than 23 million Americans suffering from diabetes and other conditions... | |
|
| News From The Journal Of Clinical Investigation: Sept. 1, 2010 | Fri, 03 Sep 2010 |
| INFECTIOUS DISEASE: Modified adenovirus malaria vaccine works a treat in mice Malaria kills more than 1 million individuals each year. Despite intensive research, there is still no malaria vaccine approved for use. A team of researchers, led by Moriya Tsuji, at the Aaron Diamond AIDS Research Center, New York, has now designed a new vaccine that provides protection from malaria in mice... | |
| Diabetes 2 Drug Metformin May Protect Against Lung Cancer In Smokers | Thu, 02 Sep 2010 |
| Two studies reveal that smokers may have a significantly lower risk of developing lung cancer and colorectal cancer with the drug metformin, which is commonly prescribed for diabetes type 2 treatment, the medical journal Cancer Prevention Research informs... | |
| More Patients Research Their Own Diseases, Seek To Manage Chronic Conditions | Thu, 02 Sep 2010 |
| News outlets report on how the delivery of health care is being changed by empowered patients. USA Today: "In the past, most patients placed their entire trust in the hands of their physician. Your doc said you needed a certain medical test, you got it. Not so much anymore. Though some doctors find the newer 'empowered' patients taxing, others ... | |
|
| New Study Singles Out Factors Linked To Cognitive Deficits In Type 2 Diabetes | Thu, 02 Sep 2010 |
| Older adults with diabetes who have high blood pressure, walk slowly or lose their balance, or believe they're in bad health, are significantly more likely to have weaker memory and slower, more rigid cognitive processing than those without these problems, according to a new study published by the American Psychological Association... | |
|
| Growing Obesity, Diabetes Epidemics In California | Thu, 02 Sep 2010 |
| A majority of adults in California are obese or overweight, and more than 2 million have been diagnosed with diabetes, according to a new study from the UCLA Center for Health Policy Research... | |
| Diabetic Macular Edema Drug Iluvien Gets FDA Priority Review | Tue, 31 Aug 2010 |
| Iluvien(R) (fluocinolone acetonide intravitreal insert), an investigational sustained drug delivery system that releases sub-microgram levels of fluocinolone acetonide for DME (diabetic macular edema) treatment, has been accepted for filing and granted Priority Review States by the FDA (Food and Drug Administration, USA), Alimera Sciences, Inc. announced today... | |
|
|
|
|
| Breastfeeding May Protect Mother From Developing Diabetes Type 2 | Sat, 28 Aug 2010 |
| A mother who breastfed her children has a considerably lower risk of developing Diabetes Type 2 when she is older, compared to a woman who had children but never breastfed, according to an article published in the American Journal of Medicine... | |
|
|
| Insulin Resistance Increases Risk Of Alzheimer's - New Study | Fri, 27 Aug 2010 |
| Rising numbers of people who are resistant to insulin or who have type 2 diabetes may also have an increased risk of Alzheimer's disease according to a new study published in Neurology. The study of 135 people from Hisayma in Fukuoka found that protein that clumps in the brain of people with Alzheimer's disease was present in higher amounts in people who were insulin resistant... | |
|
